Harrow (HROW) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Harrow is the larger company by market cap ($1.15 billion vs $1.09 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HROW | TRAX |
|---|---|---|
| Share price | $30.62 | $30.59 |
| Market cap | $1.15B | $1.09B |
| 1-day change | +0.89% | -2.55% |
| YTD return | -37.51% | — |
| 1-year return | -26.92% | — |
| 5-year return | +209.61% | — |
| Forward P/E | 11.04 | — |
| EPS (TTM) | $-0.99 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $54.85 | $49.91 |
| 52-week low | $28.54 | $14.72 |
| Distance from 52-week high | -44.18% | -38.71% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +112.28% | +128.83% |
| Average volume | 552.72K | 792.69K |
| Shares outstanding | 37.49M | 35.73M |
| Employees | 373 | 104 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Harrow
HROW stock →Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.
Healthcare · Drug Manufacturers - Specialty & Generic · 373 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Healthcare · Biotechnology · 104 employees
HROW vs TRAX FAQ
Which is bigger, Harrow or First Tracks Biotherapeutics?
Harrow (HROW) is larger, with a market capitalization of $1.15B compared with $1.09B for First Tracks Biotherapeutics (TRAX).
Are Harrow and First Tracks Biotherapeutics in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for Harrow and Biotechnology for First Tracks Biotherapeutics.